Articles published by Hyloris Pharmaceuticals SA
Hyloris to Report 2023 Full-Year Results on 14 March 2024
March 08, 2024
Via GlobeNewswire
Hyloris announces US FDA approval for Podofilox Gel
December 04, 2023
Via GlobeNewswire
Hyloris Announces Out-Licensing of Atomoxetine Oral Liquid in Canada
October 24, 2023
Via GlobeNewswire
Hyloris announces U.S. FDA Approval of Maxigesic® IV
October 18, 2023
Via GlobeNewswire
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|